ArticleESMO real world data and digital oncology2026
Real-world safety and efficacy of enzalutamide versus darolutamide in nonmetastatic castration-resistant prostate cancer: a multicenter retrospective study.
K Ishimoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.